“Highmark Inc., conspired to monopolize the city’s health care market ……..raise prices at the expense of employers and consumers……………..Highmark is one of the nation’s largest independent licensees of the Blue Cross & Blue Shield Assn. ……………….”
October 7, 2011 – 1:13 pm ET
UPMC said in a statement that it is disappointed the high court would not review the case. A spokesman for West Penn Allegheny said the health system doesn’t comment on pending litigation.
A spokesman for Highmark said, “While we’re disappointed that the U.S. Supreme Court denied our petition, the case will now proceed in the district court.”
Meanwhile, Highmark announced in June that it plans to acquire West Penn Allegheny for $475 million. However, the deal is subject to federal and state regulatory review.
West Penn Allegheny lost $48.8 million from operations in the nine months ended March 31, according to its most recent financial statement. UPMC, by comparison, reported net income of $726.8 million for the year ended June 30.
Based in Pittsburgh, Highmark is one of the nation’s largest independent licensees of the Blue Cross & Blue Shield Assn. with 4.8 million members in Pennsylvania and West Virginia.
A copy of West Penn Allegheny’s appeal to the 3rd Circuit is available here.